findmyKOL
Clinical trialNCT02730923UnknownPhase 1/PHASE2Interventional

Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)

SponsorCentre Leon BerardEnrollment72Endometrial CarcinomaHormone Receptor Positive TumorMetastatic Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Ico - Paul Papin

    Angers, France

  • Institut Sainte Catherine

    Avignon, France

  • Hôpital Jean Minjoz

    Besançon, France

  • Institut Bergonié

    Bordeaux, France

  • Centre Francois Baclesse

    Caen, France

  • Ghm Institut Daniel Hollard

    Grenoble, France

  • Centre Oscar Lambret

    Lille, France

  • Centre Léon Bérard

    Lyon, France

  • Institut Régional Du Cancer Montpellier (icm)

    Montpellier, France

  • Hcl - Chls

    Pierre-Bénite, France

  • Ico - René Gauducheau

    Saint-Herblain, France

  • Institut Gustave Roussy

    Villejuif, France

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2016
Primary completion
30 Nov 2019
Completion
31 Dec 2024
Last update posted
13 Feb 2024
Registered enrollment
72
Registry id
NCT02730923
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.